Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community‐Based Study
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Objectives: To investigate whether clinical and neuropathological differences exist between Alzheimer's disease (AD) cases with and without vascular lesions neuropathologically diagnosed using Consortium to Establish a Registry for Alzheimer's Disease (CERAD) criteria. Design: Descriptive observational study. Setting: A community‐based registry that identified incident dementia cases. Participants: Of the 124 subjects with available clinical and neuropathological assessments, 30 had AD lesions alone, and 18 had AD with vascular lesions. Patients with other neuropathological findings were excluded. Measurements: Dependent measures included demographic, clinical, and neuropathological characteristics. Neuropathological diagnoses were made using the CERAD criteria and Braak and Braak staging. Results: Of the 124 autopsied cases, 85 cases were diagnosed with neuropathological AD. Of these, 30 had pathology consistent with “pure” AD, whereas 18 had AD pathology with significant vascular lesions (AD/V). There were no differences in age, sex, or education between groups. AD/V cases had higher baseline and final Mini‐Mental State Examination (MMSE) scores than pure AD cases, but after adjusting for education, differences in MMSE scores were not statistically significant. The AD/V group had significantly lower Braak staging than the pure AD group, after adjusting for education and final MMSE scores. Conclusion: In this comparison study of AD cases with and without vascular lesions, AD/V cases had less severe AD pathology than those with AD alone, indicating that cerebrovascular disease likely contributes to the severity of cognitive impairment in those with AD. Controlling for vascular risk factors in patients with AD may have a significant effect on severity of dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152 · cited 2×
“For dementia screening, the MMSE has been demonstrated to have high validity, with good test-retest reliability.(29,30) Therefore, it was administered at subject enrollment into the ADPR and annually thereafter throughout the study.”
BackgroundMethodSilent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313 · cited 1×
“A recent study reported that subjects who exhibited silent infarcts on brain magnetic resonance imagings had a greater risk of developing dementia than those without these lesions.(13) According to another study, clinical AD is three times more likely to occur after a cerebrovascular episode.”
BackgroundObservations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 14×
“In the United States alone, there are almost 4 million persons with AD, with roughly 360,000 new cases of AD identified each year.1 The number of prevalent cases is expected to more than triple in the next 50 years, resulting in more than 14 million persons likely to have AD by 2050.1,2 Approximately 5% of those aged…”
BackgroundInfluentialFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
Vascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664
Research works printed but not linked: 37
- 10.2105/AJPH.88.9.1337 · DOI · Paper page
- 10.2307/3350099 · DOI · Paper page
- 10.1016/0197-4580(90)90024-T · DOI · Paper page
- 10.1097/00002093-199912003-00017 · DOI · Paper page
- Heyman A, 1998, Cerebral infarcts in patients with autopsy‐proven Alzheimer's disease, CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease, 51, 159
- 10.1097/00005072-199702000-00007 · DOI · Paper page
- 10.1161/01.STR.28.12.2429 · DOI · Paper page
- 10.1111/j.1532-5415.1996.tb00908.x · DOI · Paper page
- 10.1136/bmj.312.7031.608 · DOI · Paper page
- Premkumar DR, 1996, Apolipoprotein E‐epsilon 4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease, Am J Pathol, 148, 2083
- 10.1001/archneur.1995.00540310076019 · DOI · Paper page
- 10.1111/j.1532-5415.1999.tb02571.x · DOI · Paper page
- Leverenz JB, 2002, Clinical and neuropathological characteristics of hippocampal sclerosis, A community-based study, 59, 1099
- Barnhart RL, 1995, Geographically overlapping Alzheimer's disease registries, Comparisons and implications, 8, 203
- Larson EB, 1990, University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987–88, Aging (Milano), 2, 404
- Kukull WA, 1996, Apolipoprotein E in Alzheimer's disease risk and case detection, A case-control study, 49, 1143
- 10.1212/WNL.34.7.939 · DOI · Paper page
- Kukull WA, 1992, Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease, A test in population-based cases and controls, 42, 607
- 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- 10.1212/WNL.41.4.479 · DOI · Paper page
- Riley KP, 2002, Alzheimer's neurofibrillary pathology and the spectrum of cognitive function, Findings from the Nun Study, 51, 567
- Graham D, 1992, Greenfield's Neuropathology, 5th Ed, 153
- Fisher CM., 1982, Lacunar strokes and infarcts, A review, 32, 871
- 10.1212/WNL.45.3.461 · DOI · Paper page
- 10.1007/s00401-001-0493-5 · DOI · Paper page
- Erkinjuntti T, 1988, Accuracy of the clinical diagnosis of vascular dementia, A prospective clinical and post-mortem neuropathological study, 51, 1037
- 10.1016/0022-510X(90)90052-O · DOI
- 10.1001/jama.278.2.113b · doi:10.1001/jama.278.2.113b · Paper page
- 10.1001/archneur.57.10.1474 · DOI · Paper page
- Royall DR, 1998, Dementias that present with and without posterior cortical features, An important clinical distinction, 46, 98
- Royall DR, 1999, Clock drawing is sensitive to executive control, A comparison of six methods, 54, 328
- 10.1176/appi.ajp.159.1.82 · DOI · Paper page
- 10.1212/WNL.46.1.142 · DOI · Paper page
- Harrell LE, 1993, Autopsy in dementing illness, Who participates?, 7, 80
- Folstein M, 2001, MMSE, Mini‐Mental State Examination Clinical Guide
- 10.1007/978-3-7091-7508-8_11 · DOI
- Williams MA, 2002, Secondary prevention of coronary heart disease in the elderly (with emphasis on patients> or=75 years of age), An American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention, 105, 1735
Cited by
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“On the other hand, CVD has been associated with worse cognitive performance in AD and neuropathological studies report that CVD lowers the threshold for dementia in subjects with a pathological diagnosis of AD [5,6,8,9,13,17,23,51,53,81-83].”
BackgroundThe Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550
Metadata
- Authors
- Riekse, R. G., Leverenz, J. B., McCormick, W., Bowen, J. D., Teri, L., Nochlin, D., Simpson, K., Eugenio, C., Larson, E. B., & Tsuang, D.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2004-08-16
- Volume
- 52
- Issue
- 9
- Pages
- 1442-1448
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W1526046891
- Cited by
- 110
- References
- 18
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community‐Based Study. https://app.cochat.ai/papers/10.1111/j.1532-5415.2004.52405.x
- The paper
- Riekse, R. G., Leverenz, J. B., McCormick, W., Bowen, J. D., Teri, L., Nochlin, D., Simpson, K., Eugenio, C., Larson, E. B., & Tsuang, D. (2004). Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community‐Based Study. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2004.52405.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.